Stocks and Investing Stocks and Investing
Wed, January 4, 2023
[ 12:00 AM ] - WOPRAI
RJ Milligan Downgraded (BFS) to Hold on, Jan 4th, 2023
Tue, January 3, 2023
[ 12:00 AM ] - WOPRAI
Travis Steed Upgraded (BDX) to Strong Buy and Increased Target to $290 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Travis Steed Downgraded (BAX) to Hold and Held Target at $55 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jorge Araya Upgraded (BAP) to Buy and Held Target at $156 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Vijay Kumar Downgraded (AZTA) to Hold and Increased Target to $62 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Matthew Sharpe Maintained (BAH) at Buy with Increased Target to $118 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jason Goldberg Maintained (BAC) at Buy with Decreased Target to $48 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Swayampakula Ramakanth Maintained (VCEL) at Stron .. uy with Increased Target to $37 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jason Goldberg Upgraded (USB) to Buy and Increased Target to $68 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jason Goldberg Maintained (WFC) at Buy with Increased Target to $64 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jeanine Wai Maintained (XOM) at Buy with Increased Target to $129 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Daniel Politzer Upgraded (WYNN) to Buy and Increased Target to $101 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jerome Ramel Downgraded (AAPL) to Hold and Held Target at $140 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Yatin Suneja Upgraded (ACAD) to Strong Buy and Held Target at $22 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Mohit Bansal Maintained (BMY) at Hold with Increased Target to $78 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jason Goldberg Maintained (BK) at Buy with Increased Target to $64 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Maintained (ADMA) at Strong Buy with Increased Target to $4.5 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Vincent Anderson Maintained (ADM) at Strong Buy with Increased Target to $116 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Michael Schmidt Upgraded (ADAP) to Strong Buy and Held Target at $5 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Vijay Kumar Downgraded (ZBH) to Hold and Held Target at $130 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jason Goldberg Downgraded (ZION) to Sell and Decreased Target to $59 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Derek Archila Maintained (ASND) at Buy with Increased Target to $177 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Maintained (AVXL) at Strong Buy with Increased Target to $50 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jason Goldberg Maintained (C) at Hold with Increased Target to $61 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Matthew Sharpe Upgraded (CACI) to Buy and Increased Target to $355 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Derek Archila Maintained (CABA) at Buy with Increased Target to $14 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Derek Archila Downgraded (ARVN) to Hold and Decreased Target to $49 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Derek Archila Downgraded (APLS) to Hold and Held Target at $58 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Michael Brown Downgraded (APO) to Hold and Held Target at $77 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Derek Archila Maintained (CCCC) at Hold with Decreased Target to $9 on, Jan 3rd, 2023

Derek Archila Maintained (CCCC) at Hold with Decreased Target to $9 on, Jan 3rd, 2023


Published on 2024-10-28 00:42:58 - WOPRAI, Derek Archila
  Print publication without navigation


Derek Archila of Wells Fargo, Maintained "C4 Therapeutics, Inc." (CCCC) at Hold with Decreased Target from $11 to $9 on, Jan 3rd, 2023.

Derek has made no other calls on CCCC in the last 4 months.



There are 2 other peers that have a rating on CCCC. Out of the 2 peers that are also analyzing CCCC, 1 agrees with Derek's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Eric Joseph of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $15 on, Friday, November 4th, 2022


This is the rating of the analyst that currently disagrees with Derek

  • Terence Flynn of "Morgan Stanley" Initiated at Sell and Held Target at $6 on, Tuesday, October 11th, 2022
Contributing Sources